L

LSL Pharma Group Inc
XTSX:LSL

Watchlist Manager
LSL Pharma Group Inc
XTSX:LSL
Watchlist
Price: 0.53 CAD 11.58%
Market Cap: CA$64.2m

Net Margin

10.4%
Current
Improving
by 59.9%
vs 3-y average of -49.6%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
10.4%
=
Net Income
CA$2.8m
/
Revenue
CA$26.8m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
10.4%
=
Net Income
CA$2.8m
/
Revenue
CA$26.8m

Peer Comparison

Country Company Market Cap Net
Margin
CA
LSL Pharma Group Inc
XTSX:LSL
64.2m CAD
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Eli Lilly and Co
NYSE:LLY
975.2B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
549.3B USD
Loading...
US
Abbvie Inc
NYSE:ABBV
388.1B USD
Loading...
CH
Roche Holding AG
SIX:ROG
277.1B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.3B GBP
Loading...
CH
Novartis AG
SIX:NOVN
219.1B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
267.7B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...

Market Distribution

Higher than 77% of companies in Canada
Percentile
77th
Based on 4 909 companies
77th percentile
10.4%
Low
-9 940 586.9% — -85.9%
Typical Range
-85.9% — 5.5%
High
5.5% — 60 777.6%
Distribution Statistics
Canada
Min -9 940 586.9%
30th Percentile -85.9%
Median -7.8%
70th Percentile 5.5%
Max 60 777.6%

LSL Pharma Group Inc
Glance View

Market Cap
64.2m CAD
Industry
N/A

LSL Pharma Group, Inc. operates as a pharmaceutical company. The company is headquartered in Boucherville, Quebec. The company went IPO on 2011-03-08. The firm specializes in the development, manufacturing, and distribution of natural health products and dietary supplements in solid dosage forms. The firm is also engaged in selling sterile ophthalmic pharmaceutical products.

LSL Intrinsic Value
0.45 CAD
Overvaluation 15%
Intrinsic Value
Price
L
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
10.4%
=
Net Income
CA$2.8m
/
Revenue
CA$26.8m
What is LSL Pharma Group Inc's current Net Margin?

The current Net Margin for LSL Pharma Group Inc is 10.4%, which is above its 3-year median of -49.6%.

How has Net Margin changed over time?

Over the last 3 years, LSL Pharma Group Inc’s Net Margin has increased from -159% to 10.4%. During this period, it reached a low of -178.5% on Jun 30, 2023 and a high of 18.7% on Dec 31, 2024.

Back to Top